logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
J

Jonathan Barratt

university of leicester

77H-index
663Paper Count
2.3WCitation Count
Published Papers 204
Publication Date
logo
Individualised treatment effects of corticosteroids in IgA nephropathy
errEBioMedicine
IF10.8
err2026-07-14
err0
errOAAI
errDavid L. Hölscher; Nikolas E.J. Schmitz; Leon Niggemeier; Pourya Pilva; Martin Strauch; Vladimir Tesar; Jonathan Barratt; Ian S.D. Roberts; Rosanna Coppo; Laura Barisoni; Motoko Yanagita; Ulas Alabalik; Andrew D. Rule; Jaidip M. Jagtap; Eliabe S. Abreu; Claudia Seikrit; Saskia von Stillfried; Maarten W. Taal; Philip A. Kalra; Juergen Floege
errShare
errSave
Beyond galactose deficiency: redefining pathogenic IgA in IgA nephropathy
errKidney International
IF12.6
err2026-07-06
err0
PREAI
errYuemiao Zhang; Jonathan Barratt; Ming-hui Zhao; Hong Zhang; Jicheng Lv
errShare
errSave
Atomistic scattering modelling of the solution structure of human dimeric IgA1 reveals a structural and mechanistic basis for IgA nephropathy
errJournal of Biological Chemistry
IF3.9
err2026-05-14
err0
errOAAI
errJayesh S. Bhatt; See Cheng Yeo; Sam M. Ireland; Aisha Ben-Younis; Jayesh Gor; Karen Molyneux; Jonathan Barratt; Stephen J. Perkins
errShare
errSave
How should we approach the treatment of IgAN in 2025?
errNephrology Dialysis Transplantation
IF5.6
err2026-02-01
err0
errOAAI
errBarratt, Jonathan
errShare
errSave
Disease modification in immunoglobulin A nephropathy
errNephrology Dialysis Transplantation
IF5.6
err2026-02-01
err0
errOAAI
errBarratt, Jonathan
errShare
errSave
A plain language summary: long-term safety and effectiveness of atacicept in individuals with IgA nephropathy
errCurrent Medical Research and Opinion
IF2.2
err2026-01-01
err0
errOAAI
errBarratt, Jonathan; Chen, Kelly; Lafayette, Richard
errShare
errSave
A pathway to high quality clinical trials in Immunoglobulin A vasculitis nephritis: meeting proceedings from a multi-professional international collaborative workshop.
errKidney International Reports
IF5.7
err2025-12-16
err0
errOAAI
errL. Oni; R. Smith; S. Ozen; C.E. Williams; E. Davies; C. King; P. Brogan; M. Haas; J. Barratt; J. Hafkin; D. Eleftheriou; K. Keat; EMD Smith; W.Y. Ding; C.K. Cheung; C. Platt; E. Pillebout; A.J. Chetwynd; A. Alladin; A. Vaglio
errShare
errSave
Complement-Mediated Kidney Diseases: Role of Alternative Pathway in Glomerular Inflammation
errKidney International Reports
IF5.7
err2025-12-04
err0
errOAAI
errJonathan Barratt; Peter Garred; Richard A. Lafayette; Hong Zhang; Jürgen Floege
errShare
errSave
Targeting B cells in IgA nephropathy: from pathogenic insight to therapeutic horizon
errCLINICAL KIDNEY JOURNAL
IF4.6
err2025-12-01
err0
errOAAI
errRoberts, Lydia; Barratt, Jonathan
errShare
errSave
Corrigendum to “Treatment of patients with IgA nephropathy: a call for a new paradigm.” Kidney International 2025;107:640–651
errKidney International
IF12.6
err2025-11-19
err0
errOAAI
errJürgen Floege; Amelie Bernier-Jean; Jonathan Barratt; Brad Rovin
errShare
errSave
Iptacopan in patients with IgA nephropathy from East Asia
errKidney International Reports
IF5.7
err2025-11-07
err0
errOAAI
errHong Zhang; Vlado Perkovic; Jonathan Barratt; Dana V. Rizk; Brad Rovin; Hernán Trimarchi; Bart Maes; Tobias Merkel; Manasi Desai; Soudeh Ansari; Ronny Renfurm; Thomas Hach; Naoki Kashihara
errShare
errSave
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-11-01
err5
PREAI
errLafayette, Richard; Barbour, Sean J.; Brenner, Robert M.; Campbell, Kirk N.; Doan, Tom; Eren, Necmi; Floege, Jurgen; Jha, Vivekanand; Kim, Beom Seok; Liew, Adrian; Maes, Bart; Pal, Atanu; Pecoits-Filho, Roberto; Phoon, Richard K. S.; Rizk, Dana V.; Suzuki, Hitoshi; Tesar, Vladimir; Trimarchi, Hernan; Wei, Xuelian; Zhang, Hong; Barratt, Jonathan
errShare
errSave
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-11-01
err4
PREAI
errPerkovic, Vlado; Trimarchi, Hernan; Tesar, Vladimir; Lafayette, Richard; Wong, Muh Geot; Barratt, Jonathan; Suzuki, Yusuke; Liew, Adrian; Zhang, Hong; Carroll, Kevin; Jha, Vivekanand; Quevedo, Alejandra; Han, Seung Hyeok; Praga, Manuel; Chacko, Bobby; Sahay, Manisha; Cheung, Chee Kay; Kooienga, Laura; Walsh, Michael; Xia, Jing; Fajardo, Cecile; Shah, Lokesh; Hafkin, Jeffrey; Rizk, Dana V.
errShare
errSave
Is It Time to Consider Population-Based Urine Dipstick Screening for Early Detection of Kidney Disease?
errKidney International Reports
IF5.7
err2025-10-24
err0
errOAAI
errMahtab Mashayekhi; Jonathan Barratt; Areefa Alladin; Andreas Kronbichler; Amir Abdipour; Edgar Lerma; Roberto Pecoits-Filho; Kartik Kalra; Pamela Lobo Moreno; Bonnie Schneider; Stuart Miller; Sayna Norouzi
errShare
errSave
DMX-200 in Patients with Primary Focal Segmental Glomerulosclerosis: Results of the Phase 2 ACTION2 Trial
errKidney International Reports
IF5.7
err2025-10-10
err0
errOAAI
errHiddo J.L. Heerspink; Alessia Fornoni; Lesley A. Inker; Irene de Lourdes Noronha; Hernan Trimarchi; Muh Geot Wong; Alisha Smith; Robert Shepherd; Carl W. White; David Fuller; Jonathan Barratt
errShare
errSave
Safety, tolerability, and efficacy of mezagitamab (TAK-079) as add-on to standard of care therapy in individuals with primary IgA nephropathy: results from a Phase 1b study
errNephrology Dialysis Transplantation
IF5.6
err2025-10-01
err0
errOAAI
errBarratt, Jonathan; Suzuki, Yusuke; Nguyen, Van Anh; Dobler, Iwona; Li, Cheryl; Patwari, Parth; Farmer, Mk
errShare
errSave
Nefecon provides kidney benefit irrespective of baseline eGFR in patients with IgAN: a subanalysis of the NefIgArd study
errNephrology Dialysis Transplantation
IF5.6
err2025-10-01
err0
errOAAI
errBarratt, Jonathan; Lafayette, Richard; Reich, Heather; Kristensen, Jens; Jones, Russell; Floege, Jurgen; Tesar, Vladimir; Trimarchi, Hernan; Zhang, Hong; Rovin, Brad
errShare
errSave
ALIGN post-hoc analyses: Reduction in proteinuria with atrasentan across subgroups by MEST-C score, baseline hematuria and baseline UPCR
errNephrology Dialysis Transplantation
IF5.6
err2025-10-01
err0
errOAAI
errHeerspink, Hiddo J. L.; Jardine, Meg; Kohan, Donald; Lafayette, Richard; Levin, Adeera; Liew, Adrian; Zhang, Hong; Davies, Helen Twiston; Knorr, Barbara; Ansari, Soudeh; Renfurm, Ronny; Barratt, Jonathan
errShare
errSave
Sustainability and depth of UPCR reduction in patients with primary IgAN treated with nefecon: a secondary analysis of the Phase 3 NefIgArd trial
errNephrology Dialysis Transplantation
IF5.6
err2025-10-01
err0
errOAAI
errBarratt, Jonathan; Reich, Heather; Kristensen, Jens; Jones, Russell; Floege, Jurgen; Tesar, Vladimir; Trimarchi, Hernan; Zhang, Hong; Rovin, Brad; Lafayette, Richard
errShare
errSave
Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY Trial
errKidney International Reports
IF5.7
err2025-10-01
err0
errOAAI
errVlado Perkovic; Jonathan Barratt; Richard Lafayette; Adrian Liew; Yusuke Suzuki; Kevin Carroll; Chee Kay Cheung; Vladimír Tesař; Hernán Trimarchi; Muh Geot Wong; Hong Zhang; Jing Xia; Cecile Fajardo; Lokesh Shah; Jeffrey Hafkin; Dana V. Rizk
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
G
Giuseppe Remuzzi
H-index: 201 · Papers: 2.1K
K
Kamlesh Khunti
H-index: 162 · Papers: 2.1K
M
Marcello Tonelli
H-index: 162 · Papers: 996
A
André Franke
H-index: 152 · Papers: 1.2K
J
Jonathan C. Craig
H-index: 136 · Papers: 1.5K
View more